VCYT

Nasdaq

VERACYTE, INC.

Latest disclosureSeptember 22, 2026

Insider score Why 0?: 0/ 100
Qualifying buys · 30d: $0

0 purchases · 21 sales

Price by TradingView

Insider transactions 46

Limited filing history

Filters

Last 30 daysNo qualifying insider buying. Sales: $365.35K by 2 insiders.

Showing the first 6 of 46 trades on this page.

Sale disclosed

John Leite

Global Chief Commercial Off

Common Stock

Reported value: $160.6K
Reported price: $40.00 / share

Sale disclosed

Jens Holstein

Director

Common Stock

Reported value: $204.75K
Reported price: $40.9494 / share

Tax or exercise withholding

Jonathan Wygant

VP, Chief Accounting Officer

Common Stock

Value context: $61.08K
Reported price: $44.88 / share

Tax or exercise withholding

John Leite

Global Chief Commercial Off

Common Stock

Value context: $177.77K
Reported price: $44.88 / share

Tax or exercise withholding

Phillip G. Febbo

Chief Scientific & Med Officer

Common Stock

Value context: $163.32K
Reported price: $44.88 / share

Sale disclosed

Phillip G. Febbo

Chief Scientific & Med Officer

Common Stock

Reported value: $446.3K
Reported price: $42.8933 / share

Sale disclosed

Phillip G. Febbo

Chief Scientific & Med Officer

Common Stock

Reported value: $118.11K
Reported price: $43.6618 / share

Tax or exercise withholding

Rebecca Chambers

Chief Financial Officer

Common Stock

Value context: $161.7K
Reported price: $44.88 / share

Sale disclosed

Rebecca Chambers

Chief Financial Officer

Common Stock

Reported value: $106.03K
Reported price: $42.8059 / share

Sale disclosed

Rebecca Chambers

Chief Financial Officer

Common Stock

Reported value: $51.36K
Reported price: $43.714 / share

Tax or exercise withholding

Annie McGuire

EVP, General Counsel

Common Stock

Value context: $144.29K
Reported price: $44.88 / share

Sale disclosed

Annie McGuire

EVP, General Counsel

Common Stock

Reported value: $92.17K
Reported price: $42.7916 / share

Sale disclosed

Annie McGuire

EVP, General Counsel

Common Stock

Reported value: $48.04K
Reported price: $43.6718 / share

Tax or exercise withholding

Marc Stapley

Chief Executive Officer

Common Stock

Value context: $394.14K
Reported price: $44.88 / share

Sale disclosed

Muna Bhanji

Director

Common Stock

Reported value: $80.1K
Reported price: $42.97 / share

Sale disclosed

Karin Eastham

Director

Common Stock

Reported value: $168.91K
Reported price: $52.7832 / share

Sale disclosed

Karin Eastham

Director

Common Stock

Reported value: $28.33K
Reported price: $53.5504 / share

Award disclosed

Karin Eastham

Director

Common Stock

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Evan/ Fa Jones

Director

Common Stock

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

David Brent Shafer

Director

Common Stock

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Eliav Barr

Director

Common Stock

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Robert S. Epstein

Director

Common Stock

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Jens Holstein

Director

Common Stock

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Muna Bhanji

Director

Common Stock

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Award disclosed

Thomas F. Miller

Director

Common Stock

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Tax or exercise withholding

Annie McGuire

EVP, General Counsel

Common Stock

Value context: $157.36K
Reported price: $47.80 / share

Sale disclosed

Annie McGuire

EVP, General Counsel

Common Stock

Reported value: $69.03K
Reported price: $49.3061 / share

Sale disclosed

Annie McGuire

EVP, General Counsel

Common Stock

Reported value: $89.01K
Reported price: $50.1168 / share

Tax or exercise withholding

Jonathan Wygant

VP, Chief Accounting Officer

Common Stock

Value context: $65.06K
Reported price: $47.80 / share

Tax or exercise withholding

Rebecca Chambers

Chief Financial Officer

Common Stock

Value context: $176.53K
Reported price: $47.80 / share

Sale disclosed

Rebecca Chambers

Chief Financial Officer

Common Stock

Reported value: $78.85K
Reported price: $49.2836 / share

Sale disclosed

Rebecca Chambers

Chief Financial Officer

Common Stock

Reported value: $98.23K
Reported price: $50.0913 / share

Tax or exercise withholding

Phillip G. Febbo

Chief Scientific & Med Officer

Common Stock

Value context: $178.29K
Reported price: $47.80 / share

Tax or exercise withholding

Marc Stapley

Chief Executive Officer

Common Stock

Value context: $430.77K
Reported price: $47.80 / share

Exercise or conversion

Marc Stapley

Chief Executive Officer

Common Stock

Value context: $5.05M
Reported price: $36.60 / share

Sale disclosed

Marc Stapley

Chief Executive Officer

Common Stock

Reported value: $6.92M
Reported price: $50.1234 / share

Exercise or conversion

Marc Stapley

Chief Executive Officer

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context: Not a separate purchase
Exercise / conversion price: $36.60 exercise / conversion price

Understand this price

This row records an option exercise or conversion. The derivative transaction price is separate from the exercise price; it is not the stock's market price. Its row value is not shown as another stock purchase.

Tax or exercise withholding

John Leite

Global Chief Commercial Off

Common Stock

Value context: $194.02K
Reported price: $47.80 / share

Sale disclosed

John Leite

Global Chief Commercial Off

Common Stock

Reported value: $699.73K
Reported price: $50.0703 / share

Exercise or conversion

Jonathan Wygant

VP, Chief Accounting Officer

Common Stock

Value context: $595.2K
Reported price: $24.80 / share

Sale disclosed

Jonathan Wygant

VP, Chief Accounting Officer

Common Stock

Reported value: $1.09M
Reported price: $45.401 / share

Exercise or conversion

Jonathan Wygant

VP, Chief Accounting Officer

Stock Option (right to buy)

Derivative security · not the ordinary share price.

Value context: Not a separate purchase
Exercise / conversion price: $24.80 exercise / conversion price

Understand this price

Sale disclosed

Robert S. Epstein

Director

Common Stock

Reported value: $440.13K
Reported price: $44.0129 / share

Sale disclosed

Annie McGuire

SVP, General Counsel

Common Stock

Reported value: $194.13K
Reported price: $38.05 / share

Sale disclosed

Annie McGuire

SVP, General Counsel

Common Stock

Reported value: $204.08K
Reported price: $40.00 / share

Award disclosed

Kevin Richard Haas

Chief Dev and Tech Officer

Common Stock

Value context: Non-cash award
Reported price: Award · no purchase price

Understand this price

The filing reports a zero transaction price for this award. It does not mean the awarded securities have no market value.

Reporting insider	Security / transaction	Amount / price	Value	Traded / disclosed	Source
Global Chief Commercial Off	Common StockSale10b5-1	4,015$40.00 / share	$160.6K	Sep 21Filed Sep 22 · 1d later	SEC filing
Director	Common StockSale10b5-1	5,000$40.95 / share	$204.75K	Sep 14Filed Sep 16 · 2d later	SEC filing
VP, Chief Accounting Officer	Common StockExercise-price or tax withholding	1,361$44.88 / share	$61.08K	Sep 2Filed Sep 4 · 2d later	SEC filing
Global Chief Commercial Off	Common StockExercise-price or tax withholding	3,961$44.88 / share	$177.77K	Sep 2Filed Sep 4 · 2d later	SEC filing
Chief Scientific & Med Officer	Common StockExercise-price or tax withholding10b5-1	3,639$44.88 / share	$163.32K	Sep 2Filed Sep 4 · 2d later	SEC filing
Chief Scientific & Med Officer	Common StockSale10b5-12 trades	13,110avg $43.05 / share	$564.41K	Sep 4Filed Sep 4 · 0d later	2 filings 10,405 @ $42.89 · $446.3KSEC filing 2,705 @ $43.66 · $118.11KSEC filing
Chief Financial Officer	Common StockExercise-price or tax withholding10b5-1	3,603$44.88 / share	$161.7K	Sep 2Filed Sep 4 · 2d later	SEC filing
Chief Financial Officer	Common StockSale10b5-12 trades	3,652avg $43.10 / share	$157.39K	Sep 4Filed Sep 4 · 0d later	2 filings 2,477 @ $42.81 · $106.03KSEC filing 1,175 @ $43.71 · $51.36KSEC filing
EVP, General Counsel	Common StockExercise-price or tax withholding10b5-1	3,215$44.88 / share	$144.29K	Sep 2Filed Sep 4 · 2d later	SEC filing
EVP, General Counsel	Common StockSale10b5-12 trades	3,254avg $43.09 / share	$140.21K	Sep 4Filed Sep 4 · 0d later	2 filings 2,154 @ $42.79 · $92.17KSEC filing 1,100 @ $43.67 · $48.04KSEC filing
Chief Executive Officer	Common StockExercise-price or tax withholding	8,782$44.88 / share	$394.14K	Sep 2Filed Sep 4 · 2d later	SEC filing
Director	Common StockSale10b5-1	1,864$42.97 / share	$80.1K	Sep 1Filed Sep 3 · 2d later	SEC filing
Director	Common StockSale10b5-12 trades	3,729avg $52.89 / share	$197.23K	Jun 18Filed Jun 22 · 4d later	2 filings 3,200 @ $52.78 · $168.91KSEC filing 529 @ $53.55 · $28.33KSEC filing
Director	Common StockGrant or award	5,272Award · no purchase price	Non-cash award	Jun 11Filed Jun 15 · 4d later	SEC filing
Director	Common StockGrant or award	5,272Award · no purchase price	Non-cash award	Jun 11Filed Jun 15 · 4d later	SEC filing
Director	Common StockGrant or award	5,272Award · no purchase price	Non-cash award	Jun 11Filed Jun 15 · 4d later	SEC filing
Director	Common StockGrant or award	5,272Award · no purchase price	Non-cash award	Jun 11Filed Jun 15 · 4d later	SEC filing
Director	Common StockGrant or award	5,272Award · no purchase price	Non-cash award	Jun 11Filed Jun 15 · 4d later	SEC filing
Director	Common StockGrant or award	5,272Award · no purchase price	Non-cash award	Jun 11Filed Jun 15 · 4d later	SEC filing
Director	Common StockGrant or award	5,272Award · no purchase price	Non-cash award	Jun 11Filed Jun 15 · 4d later	SEC filing
Director	Common StockGrant or award	5,272Award · no purchase price	Non-cash award	Jun 11Filed Jun 15 · 4d later	SEC filing
EVP, General Counsel	Common StockExercise-price or tax withholding10b5-1	3,292$47.80 / share	$157.36K	Jun 2Filed Jun 4 · 2d later	SEC filing
EVP, General Counsel	Common StockSale10b5-12 trades	3,176avg $49.76 / share	$158.04K	Jun 4Filed Jun 4 · 0d later	2 filings 1,400 @ $49.31 · $69.03KSEC filing 1,776 @ $50.12 · $89.01KSEC filing
VP, Chief Accounting Officer	Common StockExercise-price or tax withholding	1,361$47.80 / share	$65.06K	Jun 2Filed Jun 4 · 2d later	SEC filing
Chief Financial Officer	Common StockExercise-price or tax withholding10b5-1	3,693$47.80 / share	$176.53K	Jun 2Filed Jun 4 · 2d later	SEC filing
Chief Financial Officer	Common StockSale10b5-12 trades	3,561avg $49.73 / share	$177.08K	Jun 4Filed Jun 4 · 0d later	2 filings 1,600 @ $49.28 · $78.85KSEC filing 1,961 @ $50.09 · $98.23KSEC filing
Chief Scientific & Med Officer	Common StockExercise-price or tax withholding10b5-1	3,730$47.80 / share	$178.29K	Jun 2Filed Jun 4 · 2d later	SEC filing
Chief Executive Officer	Common StockExercise-price or tax withholding10b5-1	9,012$47.80 / share	$430.77K	Jun 2Filed Jun 4 · 2d later	SEC filing
Chief Executive Officer	Common StockOption exercise or conversion10b5-1	138,051$36.60 / share	$5.05M	Jun 4Filed Jun 4 · 0d later	SEC filing
Chief Executive Officer	Common StockSale10b5-1	138,051$50.12 / share	$6.92M	Jun 4Filed Jun 4 · 0d later	SEC filing
Chief Executive Officer	Stock Option (right to buy)Option exercise or conversion10b5-1	Derivative units138,051$36.60 exercise / conversion price	Not a separate purchase	Jun 4Filed Jun 4 · 0d later	SEC filing
Global Chief Commercial Off	Common StockExercise-price or tax withholding10b5-1	4,059$47.80 / share	$194.02K	Jun 2Filed Jun 4 · 2d later	SEC filing
Global Chief Commercial Off	Common StockSale10b5-1	13,975$50.07 / share	$699.73K	Jun 4Filed Jun 4 · 0d later	SEC filing
VP, Chief Accounting Officer	Common StockOption exercise or conversion	24,000$24.80 / share	$595.2K	May 22Filed May 27 · 5d later	SEC filing
VP, Chief Accounting Officer	Common StockSale	24,000$45.40 / share	$1.09M	May 22Filed May 27 · 5d later	SEC filing
VP, Chief Accounting Officer	Stock Option (right to buy)Option exercise or conversion	Derivative units24,000$24.80 exercise / conversion price	Not a separate purchase	May 22Filed May 27 · 5d later	SEC filing
Director	Common StockSale10b5-1	10,000$44.01 / share	$440.13K	May 20Filed May 22 · 2d later	SEC filing
SVP, General Counsel	Common StockSale10b5-12 trades	10,204avg $39.03 / share	$398.21K	May 6Filed May 8 · 2d later	2 filings 5,102 @ $38.05 · $194.13KSEC filing 5,102 @ $40.00 · $204.08KSEC filing
Chief Dev and Tech Officer	Common StockGrant or award	44,221Award · no purchase price	Non-cash award	Apr 10Filed Apr 14 · 4d later	SEC filing

Congress transactions 3

All Congress filings

Purchase disclosed

Veracyte, Inc. - Common Stock (VCYT) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: March 3, 2026

Purchase disclosed

Veracyte, Inc. - Common Stock (VCYT) · Stock

The filing reports a purchase for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: February 18, 2026

Partial sale disclosed

Veracyte, Inc. - Common Stock (VCYT) · Stock

The filing reports a partial sale for the member.

Gilbert CisnerosReporting House member

Reported amount: $1,001 – $15,000Reported range; exact amount not disclosed.
Trade date: November 12, 2025

Why this buying score?

No qualifying common-equity purchases

No eligible common-equity purchase is public by this cutoff within 180 transaction-date days. Other instruments, exercises and routine activity do not contribute purchase points.

+0 pts

This score describes qualifying insider purchases at issuer level. Read the methodology

Sources and coverage

Limited filing history · Market-wide discovery does not establish complete company history. View coverage

Source: SEC EDGAR · Form 4
Issuer CIK: 0001384101
Latest public acceptance: Sep 22, 2026, 09:16 PM UTC
Score calculated: Oct 8, 2026, 03:54 PM UTC
Parser: form4-parser-1.5
Classifier: form4-classifier-1.1
Scoring methodology: insider-experimental-1.1
Availability: Public filing time, not trade date

Open a transaction's SEC filing for the primary evidence. A code P may describe an open-market or private purchase; classification is not proof of intent.

Insider activity can have many explanations. Signal Strength is not a probability of profit or a recommendation to trade.

Reporting insider

Security / transaction

Amount / price

Value

Traded / disclosed

Source

Global Chief Commercial Off

Common StockSale10b5-1

4,015$40.00 / share

$160.6K

Sep 21Filed Sep 22 · 1d later